𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lipid lowering drugs and the risk of recurrent venous thromboembolism

✍ Scribed by Delluc, Aurélien; Tromeur, Cécile; Le Moigne, Emmanuelle; Nowak, Emmanuel; Mottier, Dominique; Le Gal, Grégoire; Lacut, Karine

Book ID
119376029
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
337 KB
Volume
130
Category
Article
ISSN
0049-3848

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting the risk of venous thromboemb
Predicting the risk of venous thromboembolism recurrence
✍ John A. Heit 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

## Abstract Venous thromboembolism (VTE) is a chronic disease with a 30% ten‐year recurrence rate. The highest incidence of recurrence is in the first 6 months. Active cancer significantly increases the hazard of early recurrence, and the proportions of time on standard heparin with an APTT ≥ 0.2 a